Related Experiment Videos

Varicella at "Casa Garrahan", 2008-2013: Assessment of postexposure prophylaxis measures

Silvina Ruvinsky1, Moira Taicz1, M Guadalupe Pérez1

  • 1Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.

Insights

Prophylaxis measures effectively prevented secondary varicella cases in children with complex conditions. Acyclovir prophylaxis was well-tolerated and effective in both healthy and immunocompromised children.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Casa Garrahan (CG) serves children with complex conditions nationwide, increasing susceptibility to highly contagious diseases like varicella.
  • Varicella outbreaks in closed communities require stringent control measures due to high attack rates in susceptible individuals.

Purpose of the Study:

  • To characterize children exposed to varicella at Casa Garrahan.
  • To detail implemented varicella prophylaxis measures.
  • To evaluate the effectiveness of these prophylaxis strategies.

Main Methods:

  • Prospective cohort study conducted between 2008 and 2013.
  • Assessment of demographic and clinical characteristics, varicella history, and immunization status of exposed children.
  • Evaluation of prophylaxis measures (acyclovir, immunization, gamma globulin) and secondary attack rate.

Main Results:

  • 107 children were included; 53% were girls with a median age of 84 months.
  • 95% had underlying conditions, and 50% were immunocompromised.
  • Prophylaxis with acyclovir was administered to 61%, immunization to 10%, with no adverse effects observed and zero secondary cases within 30 days.

Conclusions:

  • Implemented varicella control measures were effective in preventing secondary cases within the CG population.
  • Acyclovir prophylaxis demonstrated efficacy and good tolerability in both healthy and immunocompromised children.
  • These findings support the successful management of varicella exposure in a high-risk pediatric population.
Abstract

Related Concept Videos